Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 181,949 | 159,301 | 145,276 | 144,923 | 149,745 |
| Cost of Goods | 83,661 | 62,507 | 54,470 | 53,467 | 55,115 |
| Gross Profit | 98,288 | 96,794 | 90,806 | 91,456 | 94,630 |
| Operating Expenses | 60,838 | 62,462 | 43,805 | 42,449 | 33,057 |
| Operating Income | 38,111 | 34,839 | 47,471 | 49,474 | 61,688 |
| Interest Expense | 22,654 | 18,394 | 15,587 | 17,339 | 19,281 |
| Other Income | 1,812 | -865 | -2,787 | 4,487 | 4,303 |
| Pre-tax Income | 17,269 | 15,580 | 29,097 | 36,622 | 46,710 |
| Income Tax | 4,733 | 6,245 | 9,491 | 8,909 | 14,770 |
| Net Income Continuous | 12,536 | 9,335 | 19,606 | 27,713 | 31,940 |
| Net Income | $12,536 | $9,335 | $19,606 | $27,713 | $31,940 |
| EPS Basic Total Ops | 0.39 | 0.29 | 0.60 | 0.86 | 0.95 |
| EPS Basic Continuous Ops | 0.39 | 0.29 | 0.60 | 0.86 | 0.95 |
| EPS Diluted Total Ops | 0.36 | 0.27 | 0.52 | 0.71 | 0.93 |
| EPS Diluted Continuous Ops | 0.32 | 0.23 | 0.49 | 0.67 | 0.87 |
| EPS Diluted Before Non-Recurring Items | 1.63 | 1.48 | 1.43 | N/A | N/A |
| EBITDA(a) | $94,247 | $76,072 | $82,215 | $84,493 | $96,583 |